Avadel Pharmaceuticals Plc (NASDAQ: AVDL)
Avadel Pharmaceuticals Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Avadel Pharmaceuticals Plc Company Info
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its products include Bloxiverz, Vazculep, Nouress, and Akovaz. It focuses on the approval of FT218, a formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was founded in 1990 and is headquartered in Dublin, Ireland.
News & Analysis
Why Shares of Avadel Soared This Week
The company got its first FDA approval.
Why Avadel Pharmaceuticals Stock Is Skyrocketing Today
The stock is rebounding from Monday's sell-off after a public statement from the company.
Why Shares of Avadel Are Sinking Today
A key regulatory decision is overdue, leaving shareholders to wonder when it might arrive.
2 Top Healthcare Stocks to Buy Right Now
One is a blue chip, the other a small-cap, but both are innovators with significant growth opportunities.
Why Jazz Pharmaceuticals' Symphony of Growth Is About to End
Competition is about to ramp up significantly in the $1.7 billion market for treating chronic sleep disorder.
Can This Small-Cap Biotech Win a $1 Billion Market Opportunity for Narcolepsy?
Will a small change in a drug's method of delivery be enough to generate over $1 billion in new sales?
Why Avadel Pharmaceuticals Stock Is Crushing It Today
Investors are excited about positive late-stage results for its narcolepsy drug.
3 Biotech Stocks That Soared This Week: Are They Buys?
Can these high-flying biotech stocks keep up their sizzling momentum?
Valuation
Earnings Transcripts
Avadel Pharmaceuticals plc (AVDL) Q3 2021 Earnings Call Transcript
AVDL earnings call for the period ending September 30, 2021.
Avadel Pharmaceuticals plc (AVDL) Q2 2021 Earnings Call Transcript
AVDL earnings call for the period ending June 30, 2021.
Avadel Pharmaceuticals plc (AVDL) Q1 2021 Earnings Call Transcript
AVDL earnings call for the period ending March 31, 2021.
Avadel Pharmaceuticals plc (AVDL) Q4 2020 Earnings Call Transcript
AVDL earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.